Evidence map›Paper›PMID 38069043›Full record

ReviewInternational journal of molecular sciences2023

Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.

Debora F Silva, Ailime L P Melo, Ana F C Uchôa, Graziela M A Pereira, Alisson E F Alves, Maria C Vasconcellos, Francisco H Xavier-Júnior, Marcele F Passos

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Special Issue: "Application of Nanotechnology in Regenerative Medicine".International journal of molecular sciences · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Special Issue "Bio-Nano Interactions 2.0".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Debora F SilvaTechnological Development Group in Biopolymers and Biomaterials from the Amazon, Graduate Program in Materials Science and Engineering, Federal University of Para, Ananindeua 67130-660, Brazil.ORCID 0000-0002-3399-4887
Ailime L P MeloTechnological Development Group in Biopolymers and Biomaterials from the Amazon, Graduate Program in Biotechnology, Federal University of Para, Belem 66075-110, Brazil.ORCID 0009-0008-5338-741X
Ana F C UchôaPharmaceutical Biotechnology Laboratory (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0001-6872-082X
Graziela M A PereiraPharmaceutical Biotechnology Laboratory (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil.
Alisson E F AlvesPost-Graduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0001-7590-7107
Maria C VasconcellosOpen Innovation Cosméticos LTDA, Curitiba 80060-100, Brazil.
Francisco H Xavier-JúniorPharmaceutical Biotechnology Laboratory (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0001-8238-3380
Marcele F PassosTechnological Development Group in Biopolymers and Biomaterials from the Amazon, Graduate Program in Materials Science and Engineering, Federal University of Para, Ananindeua 67130-660, Brazil.

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 400111/2023-3
6 · The paper itself

Abstract

Nanotechnology has played a prominent role in biomedical engineering, offering innovative approaches to numerous treatments. Notable advances have been observed in the development of medical devices, contributing to the advancement of modern medicine. This article briefly discusses key applications of nanotechnology in tissue engineering, controlled drug release systems, biosensors and monitoring, and imaging and diagnosis. The particular emphasis on this theme will result in a better understanding, selection, and technical approach to nanomaterials for biomedical purposes, including biological risks, security, and biocompatibility criteria.

Indexed as

Drug Delivery SystemsNanostructuresBiomedical EngineeringNanotechnologyTissue Engineeringcontrolled drug releasenanomaterialspolymertissue engineering

Identifiers

PMID38069043
PMCPMC10706257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.